Semler Scientific, Inc. (SMLR)

Semler Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	56.29	68.18	56.69	53.03	38.6
Revenue Growth (YoY)	-17.44%	20.28%	6.90%	37.36%	17.81%
Cost of Revenue	4.76	6.98	4.25	6.12	3.36
Gross Profit	51.54	61.2	52.43	46.91	35.25
Selling, General & Admin	25.81	32.44	30.42	23.68	16.35
Research & Development	4.79	5.77	4.81	3.78	2.94
Operating Expenses	30.6	38.21	35.23	27.46	19.29
Operating Income	20.93	22.99	17.2	19.45	15.96
Interest & Investment Income	1.88	2.47	0.49	0.01	0.02
Other Non Operating Income (Expenses)	24.95	0.02	-0.01	-	0.06
EBT Excluding Unusual Items	47.76	25.48	17.69	19.46	16.04
Merger & Restructuring Charges	-	-0.73	-	-	-
Gain (Loss) on Sale of Investments	0.13	-0.64	-	-	0.44
Pretax Income	47.88	24.1	17.69	19.46	16.49
Income Tax Expense	6.99	3.52	3.37	2.23	2.48
Net Income	40.9	20.58	14.33	17.22	14.01
Net Income to Common	40.9	20.58	14.33	17.22	14.01
Net Income Growth	98.70%	43.69%	-16.82%	22.95%	-7.14%
Shares Outstanding (Basic)	7	7	7	7	7
Shares Outstanding (Diluted)	8	8	8	8	8
Shares Change (YoY)	2.06%	-2.26%	-1.71%	0.89%	0.46%
EPS (Basic)	5.66	3.06	2.13	2.56	2.13
EPS (Diluted)	5.13	2.63	1.79	2.12	1.74
EPS Growth	95.06%	46.93%	-15.57%	21.84%	-7.45%
Free Cash Flow	24.36	20.5	15.3	15.23	14.36
Free Cash Flow Per Share	3.05	2.62	1.91	1.87	1.78
Gross Margin	91.55%	89.76%	92.50%	88.45%	91.31%
Operating Margin	37.19%	33.72%	30.35%	36.67%	41.35%
Profit Margin	72.65%	30.19%	25.27%	32.48%	36.28%
Free Cash Flow Margin	43.27%	30.07%	27.00%	28.72%	37.19%
EBITDA	21.51	23.28	17.41	19.63	16.1
EBITDA Margin	38.21%	34.15%	30.71%	37.02%	41.70%
D&A For EBITDA	0.58	0.29	0.2	0.19	0.14
EBIT	20.93	22.99	17.2	19.45	15.96
EBIT Margin	37.19%	33.72%	30.35%	36.67%	41.35%
Effective Tax Rate	14.59%	14.59%	19.03%	11.48%	15.04%

Source: S&P Capital IQ. Standard template. Financial Sources.